| Literature DB >> 35003301 |
Yu Sun1,2, Yuan Cai2, Man Xiao1, Ming-Hai Hu3, Guo-Qiang Shao2, Hui Liu2, Bing-Bing Shen2, Peng-Hui Li2, Yan-Mei Peng1,2.
Abstract
Ischemia-reperfusion (I/R) injury is one of the most common phenomena in ischemic disease or processes that causes progressive disability or even death. It has a major impact on global public health. Traditional Chinese medicine (TCM) has a long history of application in ischemic diseases and has significant clinical effect. Numerous studies have shown that the formulas or single herbs in TCM have specific roles in regulating oxidative stress, anti-inflammatory, inhibiting cell apoptosis, etc., in I/R injury. We used bibliometrics to quantitatively analyze the global output of publications on TCM in the field of I/R injury published in the period 2001-2021 to identify research hotspots and prospects. We included 446 related documents published in the Web of Science during 2001-2021. Visualization analysis revealed that the number of publications related to TCM in the field of I/R injury has increased year by year, reaching a peak in 2020. China is the country with the largest number of publications. Keywords and literature analyses demonstrated that neuroregeneration is likely one of the research hotspots and future directions of research in the field. Taken together, our findings suggest that although the inherent limitations of bibliometrics may affect the accuracy of the literature-based prediction of research hotspots, the results obtained from the included publications can provide a reference for the study of TCM in the field of I/R injury.Entities:
Year: 2021 PMID: 35003301 PMCID: PMC8731293 DOI: 10.1155/2021/4548367
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Distribution of publication years from 2001 to 2020.
Figure 2Number of documents of I/R injury in different organs.
Figure 3Spatial distribution of the citations of global publications.
Top 10 most productive countries/regions with publications on TCM in I/R injury.
| Rank | Country/region | Documents | Citations | Total link strength |
|---|---|---|---|---|
| 1st | China | 424 | 7463 | 52 |
| 2nd | USA | 27 | 462 | 37 |
| 3rd | South Korea | 9 | 234 | 3 |
| 4th | Japan | 7 | 228 | 5 |
| 5th | Australia | 5 | 90 | 6 |
| 6th | Italy | 4 | 115 | 14 |
| 7th | England | 4 | 52 | 4 |
| 8th | Pakistan | 2 | 254 | 4 |
| 9th | Iran | 2 | 56 | 10 |
| 10th | Turkey | 2 | 64 | 10 |
Figure 4Visualization of organized documents data.
Top 10 most productive organizations.
| Rank | Organizations | Documents | Citations | Total link strength |
|---|---|---|---|---|
| 1st | Beijing University of Chinese Medicine | 26 | 310 | 35 |
| 2nd | China Pharmaceutical University | 22 | 494 | 17 |
| 3rd | Chinese Academy of Medical Sciences | 19 | 310 | 57 |
| 4th | Tianjin University of Traditional Chinese Medicine | 19 | 270 | 28 |
| 5th | Fourth Military Medical University | 18 | 242 | 23 |
| 6th | Capital Medical University | 16 | 412 | 32 |
| 7th | Peking Union Medical College | 15 | 265 | 48 |
| 8th | China Academy of Chinese Medical Sciences | 15 | 175 | 32 |
| 9th | Shanghai University of Traditional Chinese Medicine | 15 | 232 | 21 |
| 10th | Zhejiang University | 15 | 167 | 21 |
Figure 5Visualization of journals documents data.
Top 10 most productive journals.
| Rank | Journals | Documents | 2020 impact factor |
|---|---|---|---|
| 1st | Journal of Ethnopharmacology | 61 | 3.69 |
| 2nd | Evidence-Based Complementary and Alternative Medicine | 31 | 1.813 |
| 3rd | Frontiers in Pharmacology | 26 | 4.225 |
| 4th | Neural Regeneration Research | 26 | 3.171 |
| 5th | Molecular Medicine Reports | 13 | 2.1 |
| 6th | Biomedicine and Pharmacotherapy | 12 | 4.545 |
| 7th | Am J Chinese Med | 11 | 3.498 |
| 8th | BMC Complementary and Alternative Medicine | 9 | 2.833 |
| 9th | Pharmacological Research | 8 | 5.893 |
| 10th | PLOS One | 8 | 2.74 |
Top 10 most productive authors.
| Rank | Authors | Documents | Citations |
|---|---|---|---|
| 1st | Yu Boyang | 10 | 215 |
| 2nd | Zhu Yan | 10 | 196 |
| 3rd | Wang Yong | 9 | 96 |
| 4th | Zhang Qian | 8 | 112 |
| 5th | Kou Junping | 8 | 174 |
| 6th | Zheng Guoqing | 7 | 117 |
| 7th | Li Chun | 6 | 76 |
| 8th | Wang Wei | 6 | 80 |
| 9th | Fan Guanwei | 6 | 129 |
| 10th | Li Fang | 6 | 58 |
Figure 6Visualization of authors documents data.
Figure 7Visualization of keywords data.
Top 10 most occurring words.
| Rank | Keywords | Occurrences | Total link strength |
|---|---|---|---|
| 1st | Apoptosis | 114 | 835 |
| 2nd | Oxidative stress | 95 | 681 |
| 3rd | Stroke | 71 | 497 |
| 4th | Expression | 69 | 509 |
| 5th | Activation | 60 | 435 |
| 6th | Neuroprotection | 57 | 460 |
| 7th | Inflammation | 53 | 364 |
| 8th | Mechanisms | 47 | 345 |
| 9th | Brain | 45 | 336 |
| 10th | Artery occlusion | 43 | 341 |
Figure 8Top 9 keywords with the strongest citation bursts.
Top 10 most cited documents.
| Rank | Title (year) | Citations |
|---|---|---|
| 1st | Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice (2006) | 130 |
| 2nd | Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats (2006) | 120 |
| 3rd | Tetramethylpyrazine reduces ischemic brain injury in rats (2004) | 103 |
| 4th | Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage (2015) | 96 |
| 5th | Neuroprotective effect of morroniside on focal cerebral ischemia in rats (2010) | 79 |
| 6th | Pharmacological actions and therapeutic applications of salvia miltiorrhiza depside salt and its active components (2012) | 70 |
| 7th | Geniposide prevents hypoxia/reoxygenation-induced apoptosis in H9c2 cells: improvement of mitochondrial dysfunction and activation of GLP-1R and the PI3K/AKT signaling pathway (2016) | 68 |
| 8th | Anti-aging implications of astragalus membranaceus (huangqi): a well-known Chinese tonic (2017) | 67 |
| 9th | Total saponins of | 66 |
| 10th | Neuroprotective herbs for stroke therapy in traditional eastern medicine (2005) | 64 |
Figure 9Visualization of citations data.
Examples of typical mechanisms of TCM against I/R injury.
| Mechanism | TCM | Model | Specific mechanism | Ref. |
|---|---|---|---|---|
| Antioxidant stress | Xueshuantong injection | MCAO | Nrf2, HO-1, and NQO1↑, activate the Nrf2-VEGF pathway to promote angiogenesis and antioxidant effects | [ |
| Salvia | MCAO | By scavenging free radical activity | [ | |
| Anti-inflammatory | Guizhi-Fuling capsules | MCAO | IL-1 | [ |
| Qingkailing | OGD/R | TNF- | [ | |
| Antiapoptosis | Tongxinluo | MCAO | Effectively protects ischemia-reperfusion injury through the Cx43/calpain II/bax/caspase-3 pathway and reduces cell death | [ |
| Tongxinluo | MCAO | Mediated by activating the PI3K/Akt pathway | [ | |
| Emodin | OGD/R | Induces the expression of Bcl-2 and GLT-1 through the ERK-1/2 signaling pathway, inhibits neuronal apoptosis and reactive oxygen generation, and reduces glutamate toxicity | [ | |
| Qingda granule | OGD/R | lncRNA GAS5, bax, caspase-3↓, miR-137, and Bcl-2 ↓ | [ | |
| Neuroprotection/neuroregeneration | Shouwu Yizhi decoction | MCAO | By upregulating the expression of miR210 induced by VEGFA, the notch pathway is activated to promote angiogenesis | [ |
| Huatuo Zaizao pill | MCAO | BDNF↑, improves the neurogenesis level of cerebral ischemic animals | [ |
Figure 10Classification of five major types of Chinese medicine.
Top ten single herb in the literature.
| Sort | Chinese name | Latin name | Documents |
|---|---|---|---|
| 1 | Danshen |
| 21 |
| 2 | Renshen |
| 16 |
| 3 | Huangqin |
| 12 |
| 4 | Honghua |
| 9 |
| 5 | Chuanxiaong |
| 7 |
| 5 | Gegen |
| 7 |
| 5 | Sanqi |
| 7 |
| 6 | Wuweizi |
| 5 |
| 7 | Danggui |
| 4 |
| 7 | Huangqi |
| 4 |
Top ten prescriptions in literature.
| Sort | Compound name | Compound components | Documents |
|---|---|---|---|
| 1 | Buyang Huanwu decoction | Huangqi, Danggui, Chishao, Dilong, Chuanxiong, Honghua, Taoren | 15 |
| 2 | Tongxinluo | Renshen, Shuizhi, Quanxie, Chishao, Chantui, Tubiechong, Wugong, Tanxiang, Jiangxiang, Ruxiang, Suanzaoren, Bingpian | 13 |
| 3 | Danhong injection | Danshen, Honghua | 8 |
| 4 | Huanglian Jiedu decoction | Huanglian, Huangqin, Huangbo, Zhizi | 6 |
| 5 | Shenfu injection | Hongshen, Heishunpian | 4 |
| 5 | Shengmai san | Renshen, Maidong, Wuweizi | 4 |
| 6 | Taohong Siwu soup | Danggui, Shudi, Chuanxiong, Baishao, Taoren, Honghua, Niuhuang, Shuiniujiao, Shexiang, Zhenzhu, Zhusha | 3 |
| 6 | Angong Niuhuang wan | Xionghuang, Huanglian, Huangqin, Zhizi, Yujin, Bingian | 3 |
| 6 | Gualou Guizhi soup | Gualou, Guizhi, Baishao, Gancao, Shengjiang, Dazao | 3 |
| 6 | Yiqi Fumai injection | Hongshen, Maidong, Wuweizi | 3 |